Butylone Stats & Data

Identity and class: Butylone is a substituted cathinone closely related to methylone; both act at monoamine transporters and can release serotonin, with butylone generally described as milder and more stimulating than MDMA. Pharmacology: In vitro work shows butylone inhibits DAT/NET/SERT and can induce 5‑HT release (MDMA‑like), supporting risks typical of serotonergic stimulants (e.g., hyperthermia, serotonin toxicity when combined inappropriately). Duration and dosing are highly variable between batches; begin with an allergy test and use a calibrated milligram scale. Avoid redosing early: peaks can be short and redose compulsion is common in cathinones, increasing cardiovascular strain, anxiety, and next‑day crash. Overheating and dehydration are key risks under hot/crowded conditions; take cooling breaks, avoid heavy exertion, sip 250–500 mL water per hour if dancing (less if sedentary), and avoid overhydration (alternate water with small electrolyte intake). Serotonin syndrome risk increases with MAOIs, DXM, tramadol, and other serotonergic combinations; seek urgent care if high fever, confusion, clonus, or severe agitation occurs. Insufflation causes pronounced nasal irritation and disproportionate side effects per user reports; oral administration is typically preferred for harm reduction. Adulteration/mis‑selling is common in stimulant markets and MDMA pills/powders may contain cathinones; use reagent/drug‑checking services where available before ingestion. People with cardiovascular disease, hypertension, seizure history, or on serotonergic or pro‑convulsant medications should avoid use. Space sessions by multiple weeks to limit tolerance and mood after‑effects; sleep, nutrition, and gentle recovery practices reduce comedown severity.